The CD28/CTLA-4 ligands, B7-1 (CD80) and B7-2 (CD86), provide a co-sti
mulatory signal necessary for optimal T cell activation. We have exami
ned the effect of blocking B7-1 and B7-2 in an in vitro system using o
valbumin-specific T cells from alpha beta TCR-transgenic mice. This sy
stem allowed us to examine the interaction of B7 co-stimulators on phy
siologic antigen-presenting cells (APC) with antigen-specific T helper
precursor (T(h)p) cells. We report that blocking T(h)p/B7-1 or B7-2 i
nteractions in a primary response differentially affects the cytokine
profile observed in a secondary stimulation, even in the absence of ad
ditional anti-B7 antibody, Engagement of B7-2 in the primary stimulati
on was found to be essential for production of the T(h)2 cytokine, IL-
4, but not the T(h)1 cytokines, IL-2 and IFN-gamma, in a secondary sti
mulation. Conversely, inclusion of the anti-B7-1 mAb in cultures using
highly purified naive T cells increased levels of IL-4 and significan
tly depressed levels of IFN-gamma, upon re-stimulation. The effect of
the anti-B7-2 mAb in reducing IL-4 production could be overcome by the
addition of recombinant IL-4 in the primary stimulation, The effects
of the anti-B7-2 mAb appear to be due to blocking and not cross-linkin
g, as F(ab) fragments mimicked the intact antibody, Taken together, ou
r data demonstrate that the interaction between T(h)p and B7-2 favors
the development of T(h)2 cells.